Pharma & Biotech

After an extended period of lateral trading, shares of biotechnology firm Ocugen are attracting renewed market interest. The catalyst appears...

The obesity treatment sector is experiencing unprecedented consolidation activity, with Viking Therapeutics shares attracting significant speculative interest following Pfizer's recent...

Shares of Plus Therapeutics experienced significant upward momentum in today's trading session, propelled by a combination of revised analyst projections...

The investment community finds itself sharply divided over Danish pharmaceutical leader Novo Nordisk. Conflicting assessments from major financial institutions have...

While Danaher's stock has faced headwinds in the current year, the biotechnology conglomerate is making strategic moves that could redefine...

Bristol-Myers Squibb, a major player in the biotechnology sector, currently faces a complex set of challenges and opportunities. The company's...

Alphabet Inc., Google's parent company, is undergoing a significant strategic transformation as it moves to spin off its life sciences...

Viking Therapeutics shares surged during Monday's pre-market session, climbing nearly 4% as takeover speculation intensified and upcoming clinical milestones drew...

Pharmaceutical giant Eli Lilly has achieved significant regulatory milestones on both sides of the Atlantic, strengthening its position in two...

A significant regulatory milestone has been achieved by biotechnology firm Regeneron, with the U.S. Food and Drug Administration granting expanded...